MTAP 缺失的实体瘤的临床试验
总计6498个结果
-
Merck Sharp & Dohme LLC终止
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.完全的
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
AbbVieGenentech, Inc.完全的
-
Safi ShahdaBayer; Genentech, Inc.完全的
-
Eli Lilly and Company完全的
-
University of CologneBoehringer Ingelheim完全的
-
Green Cross CorporationICON Clinical Research终止
-
Bristol-Myers Squibb撤销
-
Genzyme, a Sanofi Company完全的
-
sigma-tau i.f.r. S.p.A.Southern Europe New Drug Organization完全的
-
Mereo BioPharmaICON Clinical Research完全的
-
GlaxoSmithKline完全的
-
Spago Nanomedical AB招聘中
-
Dr David ZieglerEngeneic Pty Limited终止
-
Syndax Pharmaceuticals完全的
-
Jazz Pharmaceuticals完全的
-
Turning Point Therapeutics, Inc.撤销
-
Hanmi Pharmaceutical Company Limited主动,不招人
-
Turning Point Therapeutics, Inc.招聘中
-
Bio-Thera SolutionsPeking University Cancer Hospital & Institute招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
University Hospital, MontpellierSoroptimist association of Monaco招聘中